Wayne A Jones, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 4185 Seneca St, Suite 11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Marsha L Matey, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 4185 Seneca St, Suite 11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Erin M Peruzzini, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4185 Seneca St Ste 11, West Seneca, NY 14224 Phone: 716-674-8189 |
Ms. Tina M. Smith, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 550 Orchard Park Rd, Suite 101b, West Seneca, NY 14224 Phone: 716-677-4400 |
Tonya L Previglian, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 4185 Seneca St, Suite 11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Charles R Mack, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 4185 Seneca St, Suite 11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Holly A Evans-brown, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4185 Seneca St, Suite 11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Eirene H Choroser, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 4185 Seneca St, Suite11, West Seneca, NY 14224 Phone: 716-674-8189 Fax: 716-712-0469 |
Ms. Amy E. Troy, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 550 Orchard Park Rd, Suite 101b, West Seneca, NY 14224 Phone: 716-677-4400 |
News Archive
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria, containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague, is associated with intestinal inflammation in patients with Crohn's disease in their research paper published July 12 by the ISME Journal: Multidisciplinary Journal of Microbial Ecology.
As a pediatric physical therapist in Clinton, Missouri, Jessica Luechtefeld was used to a hands-on coaching approach whenever meeting with her patients at their preschools, in their homes or at the Child's Play Therapy clinic.
Chelsea Therapeutics International, Ltd. has initiated enrollment in a multinational, 12-week, double-blind Phase II trial designed to compare the efficacy and tolerability of CH-4051 against methotrexate (MTX) in 250 patients with rheumatoid arthritis (RA) who are experiencing an inadequate response to MTX treatment.
Nurse Leslie McKamey has gotten used to the 16-hour shifts, to skipping lunch, to the nightly ritual of throwing all her clothes in the laundry and showering as soon as she walks through the door to avoid potentially infecting her children.
› Verified 4 days ago